Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  General Electric Company    GE

GENERAL ELECTRIC COMPANY

(GE)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

General Electric : GE Healthcare Gets FDA Clearance for AI-Powered Cardiovascular Ultrasound System

10/12/2020 | 08:27am EST

By Michael Dabaie

GE Healthcare said it received U.S. Food and Drug Administration 510k clearance for its Ultra Edition package on Vivid cardiovascular ultrasound systems.

The healthcare business of General Electric Co. said this includes new features based on artificial intelligence that enable clinicians to acquire faster, more repeatable exams consistently.

"With the Vivid Ultra Edition, we offer AI capabilities that help address healthcare providers' two key challenges in echo exams--how time consuming the exam is and the degree of variability that exists in the quantitative results," said Dagfinn Saetre, general manager of cardiovascular ultrasound at GE Healthcare.

Write to Michael Dabaie at michael.dabaie@wsj.com

(END) Dow Jones Newswires

10-12-20 0826ET

All news about GENERAL ELECTRIC COMPANY
12:32pGENERAL ELECTRIC : Powered by GE Technology, YPF Luz's La Plata Cogeneration II ..
AQ
11/29GE HEALTHCARE : Expands AI, Digital and Imaging Solutions at #RSNA2020, Helping ..
BU
11/27TIMELINE-Japan's electricity market reforms
RE
11/26GENERAL ELECTRIC : UK Mega Offshore Wind Farm - to Debut GE Haliade-X Technology..
AQ
11/26GENERAL ELECTRIC : GE Healthcare Announces First X-ray AI to Help Assess Endotra..
AQ
11/25U.S. Consumer Spending Rises for Sixth Straight Month -- 3rd Update
DJ
11/25TODAY'S LOGISTICS REPORT : Building Vaccine Supply Chains; Delivery's Uphill Cli..
DJ
11/25GENERAL ELECTRIC : GE Healthcare Announces U.S. FDA approval of macrocyclic MRI ..
AQ
11/24NEWS HIGHLIGHTS : Top Company News of the Day
DJ
11/24NEWS HIGHLIGHTS : Top Company News of the Day
DJ
More news
Financials (USD)
Sales 2020 79 649 M - -
Net income 2020 3 511 M - -
Net Debt 2020 20 304 M - -
P/E ratio 2020 30,4x
Yield 2020 0,39%
Capitalization 88 913 M 88 913 M -
EV / Sales 2020 1,37x
EV / Sales 2021 1,38x
Nbr of Employees 189 400
Free-Float 74,3%
Chart GENERAL ELECTRIC COMPANY
Duration : Period :
General Electric Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GENERAL ELECTRIC COMPANY
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 21
Average target price 9,62 $
Last Close Price 10,15 $
Spread / Highest target 18,2%
Spread / Average Target -5,19%
Spread / Lowest Target -31,0%
EPS Revisions
Managers
NameTitle
H. Lawrence Culp Chairman & Chief Executive Officer
Carolina Dybeck-Happe Chief Financial Officer & Senior Vice President
Victor Abate Chief Technology Officer & Senior Vice President
James S. Tisch Independent Director
Francisco D'Souza Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
GENERAL ELECTRIC COMPANY-9.05%88 913
HONEYWELL INTERNATIONAL INC.16.50%144 688
SIEMENS AG-3.09%108 157
3M COMPANY-3.34%98 360
ILLINOIS TOOL WORKS INC.16.94%66 488
HITACHI, LTD.-13.25%36 751